A Good Number of Cancer Patients in Mid-Stage Trials Get Drugs Later Approved

(MedPage Today) -- One in six patients in phase II oncology clinical trials received a treatment that was eventually approved by the FDA, according to a longitudinal study.
In a sample of 400 phase II trials that included 25,000 participants...